Moore Capital Management’s Dentsply Sirona XRAY Stock Holding History

Moore Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.64M	Sell	437,556 -13,096	-3%	-$143K	0.07%	246
2026 Q1	$5.23M	Sell	450,652 -27,603	-6%	-$344K	0.11%	148
2025 Q4	$5.47M	Buy	478,255 +123,068	+35%	+$1.44M	0.08%	238
2025 Q3	$4.51M	Buy	355,187 +214,738	+153%	+$3.12M	0.06%	260
2025 Q2	$2.23M	Sell	140,449 -315,478	-69%	-$4.72M	0.03%	310
2025 Q1	$6.81M	Buy	455,927 +337,492	+285%	+$5.98M	0.14%	145
2024 Q4	$2.25M	Buy	+118,435	New	+$2.5M	0.03%	317
2022 Q1	–	Sell	-121,501	Closed	-$6.78M	–	866
2021 Q4	$6.78M	Sell	121,501 -150,513	-55%	-$8.28M	0.13%	169
2021 Q3	$15.8M	Buy	+272,014	New	+$16.8M	0.24%	85

Other funds holding XRAY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Moore Capital Management's XRAY Position: Q2 2026 in Review

Moore Capital Management reduced its Dentsply Sirona (XRAY) stake by 2.9% in Q2 2026, selling an estimated $143K and leaving 437,556 shares worth $4.64M. The position accounts for 0.07% of the portfolio, ranked #246.

Moore Capital Management first reported a position in XRAY in Q3 2021 and has held it in 9 quarters since. The position peaked at $15.8M in Q3 2021. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

Moore Capital Management held 437,556 shares of Dentsply Sirona worth $4.64M as of Q2 2026.
Moore Capital Management sold 13,096 Dentsply Sirona shares in Q2 2026, an estimated $143K.
Dentsply Sirona made up 0.07% of Moore Capital Management's portfolio in Q2 2026, its #246 holding.
Moore Capital Management first reported a position in Dentsply Sirona in Q3 2021 and has held it in 9 quarters since.
Moore Capital Management's Dentsply Sirona position peaked at $15.8M in Q3 2021.
373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.